Overview
Levonordefrin acts as a topical nasal decongestant and vasoconstrictor, most often used in dentistry.
Indication
Used as a topical nasal decongestant and vasoconstrictor in dentistry.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2023/05/25 | Not Applicable | Completed | Minia University | ||
2020/07/20 | Phase 3 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Caresteam Health, Inc. | 31382-931 | SUBCUTANEOUS | 0.05 mg in 1 mL | 12/12/2017 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| 2% POLOCAINE DENTAL WITH LEVONORDEFRIN 1:20,000 | dentsply canada limited | 00874639 | Solution - Block/Infiltration | 0.05 MG / ML | 12/31/1990 |
| ISOCAINE HCL INJ 2% | novocol pharmaceutical of canada inc | 00393711 | Solution - Block/Infiltration | 0.05 MG / ML | 12/31/1977 |
| CARBOCAINE 2% WITH NEO-COBEFRIN | novocol pharmaceutical of canada inc | 02474182 | Solution - Block/Infiltration | 0.05 MG / ML | 7/30/2019 |
| CARBOCAINE 2% WITH NEO-COBEFRIN | kodak canada inc. | 02263580 | Solution - Block/Infiltration | 0.05 MG / ML | 4/22/2005 |
| CARBOCAINE 2% WITH NEO-COBEFRIN | carestream health canada company | 02281414 | Solution - Block/Infiltration | 0.05 MG / ML | 9/1/2006 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.